Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'IN-VITRO ACTIVITY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 675 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Linder, MR; Podlech, J
      Synthesis of beta-lactams from diazoketones and imines: The use of microwave irradiation

      ORGANIC LETTERS
    2. Linder, MR; Frey, WU; Podlech, J
      Diazoketones as precursors in beta-lactam synthesis. New insights into themechanism of the photochemically induced Staudinger reaction

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
    3. De Nardi, C; Braggio, S; Ferrari, L; Fontana, S
      Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay for the determination of sanfetrinem in human plasma

      JOURNAL OF CHROMATOGRAPHY B
    4. Bhanot, SK; Singh, M; Chatterjee, NR
      The chemical and biological aspects of fluoroquinolones: Reality and dreams

      CURRENT PHARMACEUTICAL DESIGN
    5. Williamson, JS
      Helicobacter pylori: Current chemotherapy and new targets for drug design

      CURRENT PHARMACEUTICAL DESIGN
    6. Arikan, S; Rex, JH
      Lipid-based antifungal agents: Current status

      CURRENT PHARMACEUTICAL DESIGN
    7. McGinnis, MR; Nordoff, N; Li, RK; Pasarell, L; Warnock, DW
      Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B

      MEDICAL MYCOLOGY
    8. Beauvais, A; Latge, JP
      Membrane and cell wall targets in Aspergillus fumigatus

      DRUG RESISTANCE UPDATES
    9. Vicente, MF; Cabello, A; Platas, G; Basilio, A; Diez, MT; Dreikorn, S; Giacobbe, RA; Onishi, JC; Meinz, M; Kurtz, MB; Rosenbach, M; Thompson, J; Abruzzo, G; Flattery, A; Kong, L; Tsipouras, A; Wilson, KE; Pelaez, F
      Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum

      JOURNAL OF APPLIED MICROBIOLOGY
    10. Dougherty, TJ; Beaulieu, D; Barrett, JF
      New quinolones and the impact on resistance

      DRUG DISCOVERY TODAY
    11. Hossain, MA; Ghannoum, MA
      New developments in chemotherapy for non-invasive fungal infections

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    12. Groll, AH; Walsh, TJ
      Caspofungin: pharmacology, safety and therapeutic potential in superficialand invasive fungal infections

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    13. Bonfiglio, G; Furneri, PM
      Novel streptogramin antibiotics

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    14. Blondeau, JM
      Clinical utility of the new fluoroquinolones for treating respiratory and urinary tract infections

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    15. Bryskier, A
      Anti-anaerobic activity of antibacterial agents

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    16. Yassin, HM; Dever, LL
      Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    17. Egan, TJ
      Quinoline antimalarials

      EXPERT OPINION ON THERAPEUTIC PATENTS
    18. Berrington, AW; Perry, JD; Gould, EK
      Bactericidal activity of moxifloxacin against Staphylococcus aureus

      CLINICAL MICROBIOLOGY AND INFECTION
    19. Pascual, A; Ballesta, S; Garcia, I; Perea, EJ
      Uptake and intracellular activity of ketolide HMR 3647 in human phagocyticand non-phagocytic cells

      CLINICAL MICROBIOLOGY AND INFECTION
    20. Ziglam, HM; Finch, RG
      Limitations of presently available glycopeptides in the treatment of Gram-positive infection

      CLINICAL MICROBIOLOGY AND INFECTION
    21. Marchese, A; Schito, GC
      The oxazolidinones as a new family of antimicrobial agent

      CLINICAL MICROBIOLOGY AND INFECTION
    22. Felmingham, D
      Microbiological profile of telithromycin, thee first ketolide antimicrobial

      CLINICAL MICROBIOLOGY AND INFECTION
    23. Groll, AH; Walsh, TJ
      Uncommon opportunistic fungi: new nosocomial threats

      CLINICAL MICROBIOLOGY AND INFECTION
    24. Hollister, AS; Agarwal, V; Dain, B; Lettieri, J
      Absence of drug interaction between oral moxifloxacin and intramuscular morphine sulfate in healthy volunteers

      CLINICAL DRUG INVESTIGATION
    25. Obaji, A; Sethi, S
      Acute exacerbations of chronic bronchitis - What role for the new fluoroquinolones?

      DRUGS & AGING
    26. Culley, CM; Lacy, MK; Klutman, N; Edwards, B
      Moxifloxacin: Clinical efficacy and safety

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    27. Valgus, JM
      Caspofungin - The first of a new class of antifungal agents

      CANCER PRACTICE
    28. Paladino, JA
      Is more than one quinolone needed in clinical practice?

      ANNALS OF PHARMACOTHERAPY
    29. Amsden, GW; Amankwa, K
      Pneumococcal resistance: The treatment challenge

      ANNALS OF PHARMACOTHERAPY
    30. Ally, R; Schurmann, D; Kreisel, W; Carosi, G; Aguirrebengoa, K; Dupont, B; Hodges, M; Troke, P; Romero, AJ
      A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

      CLINICAL INFECTIOUS DISEASES
    31. Villanueva, A; Arathoon, EG; Gotuzzo, E; Berman, RS; DiNubile, MJ; Sable, CA
      A randomized double-blind study of caspofungin versus amphotericin for thetreatment of candidal esophagitis

      CLINICAL INFECTIOUS DISEASES
    32. Gales, AC; Jones, RN; Turnidge, J; Rennie, R; Ramphal, R
      Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999

      CLINICAL INFECTIOUS DISEASES
    33. Krasemann, C; Meyer, J; Tillotson, G
      Evaluation of the clinical microbiology profile of moxifloxacin

      CLINICAL INFECTIOUS DISEASES
    34. Benoit-Vical, F; Valentin, A; Mallie, M; Bessiere, JM
      Antiplasmodial activity of Cochlospermum planchonii and C-tinctorium tubercle essential oils

      JOURNAL OF ESSENTIAL OIL RESEARCH
    35. Li, JB; Yang, P; Gao, F; Han, GY; Yu, KB
      Novel lanthanide complexes of ciprofloxacin: Synthesis, characterization, crystal structure and in vitro antibacterial activity studies

      CHINESE JOURNAL OF CHEMISTRY
    36. Bottari, B; Maccari, R; Monforte, F; Ottana, R; Vigorita, MG; Bruno, G; Nicolo, F; Rotondo, A; Rotondo, E
      Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. PartXI

      BIOORGANIC & MEDICINAL CHEMISTRY
    37. Ow, WB; Luo, W; Park, YD; Zhou, HM
      Chaperone-like activity of peptidyl-prolyl cis-trans isomerase during creatine kinase refolding

      PROTEIN SCIENCE
    38. Bottari, B; Maccari, R; Monforte, F; Ottana, R; Rotondo, E; Vigorita, MG
      Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    39. Hoeffken, G; Meyer, HP; Winter, J; Verhoef, L
      The efficacy and safety of two oral moxifloxacin regimens compared to oralclarithromycin in the treatment of community-acquired pneumonia

      RESPIRATORY MEDICINE
    40. Hammerschlag, MR
      Mycoplasma pneumoniae infections

      CURRENT OPINION IN INFECTIOUS DISEASES
    41. Bonini, BF; Femoni, C; Comes-Franchini, M; Foschi, M; Mazzanti, G; Ricci, A; Varchi, G
      One pot synthesis of new beta-lactams containing the ferrocene moiety

      SYNLETT
    42. Koc, AN; Uksal, U; Oymak, O
      Case report. Successfully treated subcutaneous infection with Sporothrix schenckii in Turkey

      MYCOSES
    43. Delhaes, L; Abessolo, H; Biot, C; Berry, L; Delcourt, P; Maciejewski, L; Brocard, J; Camus, D; Dive, D
      In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites

      PARASITOLOGY RESEARCH
    44. Yoshimura, H; Ishimaru, M; Endoh, YS; Kojima, A
      Antimicrobial susceptibility of Pasteurella multocida isolated from cattleand pigs

      JOURNAL OF VETERINARY MEDICINE SERIES B-INFECTIOUS DISEASES AND VETERINARYPUBLIC HEALTH
    45. Wu, YJ; Su, WG
      Recent developments on ketolides and macrolides

      CURRENT MEDICINAL CHEMISTRY
    46. Malabarba, A; Ciabatti, R
      Glycopeptide derivatives

      CURRENT MEDICINAL CHEMISTRY
    47. Materna, V; Holm, PS; Dietel, M; Lage, H
      Kinetic characterization of ribozymes directed against the cisplatin resistance-associated ABC transporter cMOAT/MRP2/ABCC2

      CANCER GENE THERAPY
    48. Kowalski, P; Wichert, A; Holm, PS; Dietel, M; Lage, H
      Selection and characterization of a high-activity ribozyme directed against the antineoplastic drug resistance-associated ABC transporter BCRP/MXR/ABCG2

      CANCER GENE THERAPY
    49. Lopez, H; Vilches, V; Scarano, S; Stepanik, D; Smayevsky, J; Lemme, L; Cardenosa, O; Ambler, J; Sucari, A
      Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    50. Kumarasinghe, G; Chow, C; Tambyah, PA
      Widespread resistance to new antimicrobials in a university hospital before clinical use

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    51. Alou, L; Sevillano, D; Bugella, JH; Fuentes, F; Gomez-Lus, ML; Prieto, J
      Evaluation of two in vitro pharmacodynamic simulation models: Microfiltration versus centrifugation-filtration

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    52. Bastert, J; Schaller, M; Korting, HC; Evans, EGV
      Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    53. Zhang, YL; Li, JT
      The in vitro activity of sulbactam combined with third generation cephalosporins against third generation cephalosporin-resistant bacteria

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    54. Shimizu, A; Wakita, Y; Nagase, S; Okabe, M; Koji, T; Hayashi, T; Nagase, N; Sasaki, A; Kawano, J; Yamashita, K; Takagi, M
      Antimicrobial susceptibility of Staphylococcus intermedius isolated from healthy and diseased dogs

      JOURNAL OF VETERINARY MEDICAL SCIENCE
    55. Robinson, VK; Sato, E; Nelson, DK; Camhi, SL; Robbins, RA; Hoyt, JC
      Peroxynitrite inhibits inducible (Type 2) nitric oxide synthase in murine lung epithelial cells in vitro

      FREE RADICAL BIOLOGY AND MEDICINE
    56. Sato, E; Koyama, S; Camhi, SL; Nelson, DK; Robbins, RA
      Reactive oxygen and nitrogen metabolites modulate fibronectin-induced fibroblast migration in vitro

      FREE RADICAL BIOLOGY AND MEDICINE
    57. Kessler, RE
      Cefepime microbiologic profile and update

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    58. Wellington, M; Gigliotti, F
      Update on antifungal agents

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    59. Savage, PB
      Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of Gram-negative bacteria

      ANNALS OF MEDICINE
    60. Black, JA; Moland, ES; Chartrand, SA; Thomson, KS
      Activity of faropenem against resistant isolates of Streptococcus pneumoniae

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    61. Lopez, H; Stepanik, D; Vilches, V; Scarano, S; Sarachian, B; Mikaelian, G; Finlay, J
      Comparative in vitro activity of gemifloxacin against gram-positive and gram-negative clinical isolates in Argentina

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    62. Giamarellos-Bourboulis, EJ; Xirouchaki, E; Giamarellou, H
      Interactions of colistin and rifampin on multidrug-resistant Acinetobacterbaumannii

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    63. Rhomberg, PR; Biedenbach, DJ; Jones, RN
      Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    64. Palacin, C; Tarrago, C; Agut, J; Guglietta, A
      In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    65. Kuria, KAM; De Coster, S; Muriuki, G; Masengo, W; Kibwage, I; Hoogmartens, J; Laekeman, GM
      Antimalarial activity of Ajuga remota Benth (Labiatae) and Caesalpinia volkensii Harms (Caesalpiniaceae): in vitro confirmation of ethnopharmacological use

      JOURNAL OF ETHNOPHARMACOLOGY

    66. Telithromycin - Ketek (R) - Levviax (R) - Ketolide antibiotic

      DRUGS OF THE FUTURE

    67. ABT-773 - A-195773.0 - Ketolide antibiotic

      DRUGS OF THE FUTURE

    68. Gatifloxacin - Tequin (R) - Gatiflo (R) - Quinolone antibacterial

      DRUGS OF THE FUTURE
    69. Poreba, K; Opolski, A; Wietrzyk, J; Kowalska, M
      Synthesis and antiproliferative activity in vitro of new derivatives of 3-aminopyrazolo[3,4-b]pyridine - Part 1. Reaction of 3-aminopyrazolo[3,4-b]pyridine with 1,3-, 1,4-diketones and alpha,beta-unsaturated ketones

      ARCHIV DER PHARMAZIE
    70. Nawrocka, W; Sztuba, B; Opolski, A; Wietrzyk, J; Kowalska, MW; Glowiak, T
      Synthesis and antiproliferative activity in vitro of novel 1,5-benzodiazepines. Part II

      ARCHIV DER PHARMAZIE
    71. Sullivan, JT; Lettieri, JT; Liu, P; Heller, AH
      The influence of age and gender on the pharmacokinetics of moxifloxacin

      CLINICAL PHARMACOKINETICS
    72. Lettieri, J; Vargas, R; Agarwal, V; Liu, P
      Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers

      CLINICAL PHARMACOKINETICS
    73. Alovero, F; Barnes, A; Nieto, M; Mazzieri, MR; Manzo, RH
      Comparative study of new benzenesulphonamide fluoroquinolones structurallyrelated to ciprofloxacin against selected ciprofloxacin-susceptible and -resistant Gram-positive cocci

      Journal of antimicrobial chemotherapy
    74. Cordero, E; Bouza, E; Ruiz, I; Pachon, J
      Cefepime versus cefotaxime for empirical treatment of bacterial pneumonia in HIV-infected patients: an open, randomized trial

      Journal of antimicrobial chemotherapy
    75. Pradines, B; Fusai, T; Daries, W; Laloge, V; Rogier, C; Millet, P; Panconi, E; Kombila, M; Parzy, D
      Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum

      Journal of antimicrobial chemotherapy
    76. Hallgren, A; Abednazari, H; Ekdahl, C; Hanberger, H; Nilsson, M; Samuelsson, A; Svensson, E; Nilsson, LE
      Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems

      Journal of antimicrobial chemotherapy
    77. Yoshizumi, S; Takahashi, Y; Murata, M; Domon, H; Furuya, N; Ishii, Y; Matsumoto, T; Ohno, A; Tateda, K; Miyazaki, S; Yamaguchi, K
      The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice

      Journal of antimicrobial chemotherapy
    78. Douthwaite, S; Champney, WS
      Structures of ketolides and macrolides determine their mode of interactionwith the ribosomal target site

      Journal of antimicrobial chemotherapy
    79. Hammerschlag, MR; Roblin, PM; Bebear, CM
      Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens

      Journal of antimicrobial chemotherapy
    80. Hryniewicz, K; Szczypa, K; Sulikowska, A; Jankowski, K; Betlejewska, K; Hryniewicz, W
      Antibiotic susceptibility of bacterial strains isolated from urinary tractinfections in Poland

      Journal of antimicrobial chemotherapy
    81. Fornas, FL; Garcia, FM; Salmeron, JP; Conesa, DR; Sanchez, RC; Alberola, AG; Gomez, JR; Gomez, JG; Chavarri, MV
      Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis dueto penicillin- and ceftriaxone-resistant Streptococcus pneumoniae

      Journal of antimicrobial chemotherapy
    82. Jonas, D; Engels, I; Friedhoff, C; Spitzmuller, B; Daschner, FD; Frank, U
      Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila

      Journal of antimicrobial chemotherapy
    83. Bachand, F; Triki, F; Autexier, C
      Human telomerase RNA-protein interactions

      NUCLEIC ACIDS RESEARCH
    84. Jellison, TK; McKinnon, PS; Rybak, MJ
      Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam

      PHARMACOTHERAPY
    85. Rodvold, KA
      Pharmacodynamics of antiinfective therapy: Taking what we know to the patient's bedside

      PHARMACOTHERAPY
    86. Bearden, DT; Neuhauser, MM; Garey, KW
      Telithromycin: An oral ketolide for respiratory infections

      PHARMACOTHERAPY
    87. Bachand, F; Autexier, C
      Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions

      MOLECULAR AND CELLULAR BIOLOGY
    88. Miyahara, T; Tonoyama, H; Watanabe, M; Okajima, A; Miyajima, S; Sakuma, T; Nemoto, N; Takayama, K
      Stimulative effect of cadmium on prostaglandin E-2 production in primary mouse osteoblastic cells

      CALCIFIED TISSUE INTERNATIONAL
    89. Kanemitsu, K; Nishino, T; Kunishima, H; Okamura, N; Takemura, H; Yamamoto, H; Kaku, M
      Quantitative determination of gelatinase activity among enterococci

      JOURNAL OF MICROBIOLOGICAL METHODS
    90. Schwendener, RA; Friedl, K; Depenbrock, H; Schott, H; Hanauske, AR
      In vitro activity of liposomal N(4)octadecyl-1-beta-D-arabinofurano-sylcytosine (NOAC), a new lipophilic derivative of 1-beta-D-arabino-furanocylcytosine on biopsized clonogenic human tumor cells and hematopoietic precursor cells

      INVESTIGATIONAL NEW DRUGS
    91. Boyles, JR; Baird, MC; Campling, BG; Jain, N
      Enhanced anti-cancer activities of some derivatives of titanocene dichloride

      JOURNAL OF INORGANIC BIOCHEMISTRY
    92. Allington, DR; Rivey, MP
      Quinupristin/dalfopristin: A therapeutic review

      CLINICAL THERAPEUTICS
    93. Zhao, J; Kong, FR; Li, R; Wang, XH; Wan, Z; Wang, DL
      Identification of Aspergillus fumigatus and related species by nested PCR targeting ribosomal DNA internal transcribed spacer regions

      JOURNAL OF CLINICAL MICROBIOLOGY
    94. Chevalier, P; Rey, J; Pasquier, O; Rouzier-Panis, R; Harding, N; Montay, G
      Multiple-dose pharmacokinetics and safety of two regimens of quinupristin/dalfopristin (Synercid (R)) in healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    95. Mitten, MJ; Meulbroek, J; Nukkala, M; Paige, L; Jarvis, K; Oleksijew, A; Tovcimak, A; Hernandez, L; Alder, JD; Ewing, P; Or, YS; Ma, Z; Nilius, AM; Mollison, K; Flamm, RK
      Efficacies of ABT-773, a new ketolide, against experimental bacterial infections

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    96. Kenny, GE; Cartwright, FD
      Susceptibilities of Mycoplasma hominis, M-pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    97. Fischer, S; Adam, D
      Effects of moxifloxacin on neutrophil phagocytosis, burst production, and killing as determined by a whole-blood cytofluorometric method

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    98. Ackermann, G; Tang, YJ; Kueper, R; Heisig, P; Rodloff, AC; Silva, J; Cohen, SH
      Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    99. Oh, H; El Amin, N; Davies, T; Appelbaum, PC; Edlund, C
      gyrA Mutations associated with quinolone resistance in Bacteroides fragilis group strains

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    100. Zhanel, GG; Saunders, DG; Hoban, DJ; Karlowsky, JA
      Influence of human serum on antifungal pharmacodynamics with Candida albicans

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 13:16:30